From: Antibody seropositivity and endemicity of chikungunya and Zika viruses in Nigeria
Sign and symptoms | Mono-infection (% sign & symptoms) | |
---|---|---|
Anti-chikungunya positive (N = 565) | Anti-Zika positive (N = 172) | |
Headaches | 84.1% (475/565) | 93.0% (160/172) |
Exanthema | 37.2% (210/565) | 31.3% (54/172) |
Fever | 87.1% (492/565) | 95.9% (165/172) |
Abdominal pain | 17.8% (101/565) | 7% (12/172) |
Diarrhoea | 14.5% (82/565) | 4.7% (8/172) |
Myalgia | 70.6% (399/565) | 55.8% (96/172) |
Vomiting | 15.8% (89/565) | 26.2% (45/172) |
Generalised body pains | 90.6% (512/565) | 62.2% (107/172) |
Arthralgia | 61.1% (345/565) | 69.8% (120/172) |
Edema | 10.4% (59/565) | 0.0% (0/172) |
Maculopapular | 0.0% (0/565) | 8.1% (14/172) |
Retro-orbital pain | 2.1% (12/565) | 14.5% (25/172) |
Nausea | 0.9% (5/565) | 7.0% (12/172) |
Non-purulent conjunctivitis | 0.4% (2/565) | 2.9% (5/172) |
Leukopenia | 50.4% (285/565) | 45.3% (78/172) |